Re: "cost shifting and timeliness of drug formulary recommendations in atlantic canada," healthcare policy, vol. 5, no. 3, 2010
- PMID: 21804834
- PMCID: PMC2929892
Re: "cost shifting and timeliness of drug formulary recommendations in atlantic canada," healthcare policy, vol. 5, no. 3, 2010
References
-
- Grootendorst “Beneficiary Cost Sharing Under Canadian Provincial Prescription Drug Benefit Programs: History and Assessment.”. PharmacoEconomics. 2002;9(2):79–99. - PubMed
-
- Marra C.A., Lynd L.D., Anis A.H., Esdaile J.M. “Approval Process and Access to Prescription Drugs in Canada.”. Arthritis Care & Research. 2006;55(1):9–11. - PubMed
-
- McMahon M., Morgan S., Mitton C. “The Common Drug Review: A NICE Start for Canada?”. Health Policy. 2006;77(3):339–51. - PubMed
LinkOut - more resources
Full Text Sources
